CNCR

Fund Description
The Loncar Cancer Immunotherapy ETF seeks to track the LCINDX index. It is made up of a basket of companies that develop therapies to treat cancer by harnessing the body s own immune system. Immunotherapy is a transformational field within the biotechnology space that is expected to become the foundational treatment for cancer over the next ten years. A sector ETF focusing on a unique technology like cancer immunotherapy allows investors to focus on interest areas more precisely than broad indices. LCINDX is an equal-weighted index containing both large pharmaceutical and growth-oriented biotechnology companies that are leading in this approach.
Fund Profile
Fund Name Loncar Cancer Immunotherapy ETF
Fund Exchange Ticker CNCR
Fund Sponsor Exchange Traded Concepts
Fund ISIN US26922A8264
Net Expense Ratio 0.79 %
Fund Inception Date 13 October 2015
Fund Legal Structure ETF (Open end fund)
Exchange NASDAQ
Listing Country Code US
Fund Investment Objective
ETF Type Specific US Equities - Industry Sector
Asset Class Equities (Stocks)
Index Linked Passive
Index Name Loncar Cancer Immunotherapy Index
Index Provider Loncar Investments
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent North America
Key Statistics
Return As of Date 15 January 2019
Asset Under Management 41.92 Million (USD)
1 Month Total Return 1.26 %
Year To Date Return 10.95 %
1 Year Total Return -18.52 %
3 Year Annualized Total Return -0.71 %
NAV 20.9593
Share Outstanding 2,000,000
Top 10 Holdings (15 January 2019)
Constituent Name Constituent Ticker Constituent Type Weighting
MIRATI THERAPEUTICS INC MRTX EQUI 0.0612000000
BLUEBIRD BIO INC BLUE EQUI 0.0460000000
SEATTLE GENETICS INC SGEN EQUI 0.0458000000
NEKTAR THERAPEUTICS NKTR EQUI 0.0454000000
DYNAVAX TECHNOLOGIES CORP DVAX EQUI 0.0450000000
CYTOMX THERAPEUTICS INC CTMX EQUI 0.0443000000
BEIGENE LTD-ADR BGNE EQUI 0.0425000000
ALLOGENE THERAPEUTICS INC ALLO EQUI 0.0415000000
REGENERON PHARMACEUTICALS REGN EQUI 0.0415000000
MORPHOSYS AG ADR MOR EQUI 0.0414000000